CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Current assets
Cash	$ 5,965	$ 9,375
Prepaid drug product for testing	1,117	376
Other current assets	353	902
Total current assets	7,435	10,653
Fixed assets
Furniture, fixtures & equipment	984	708
Less accumulated depreciation	(330)	(94)
Property, Plant and Equipment, Net	654	614
Other assets
Technology licenses	2,500	2,500
Less accumulated amortization	(1,731)	(1,571)
Intangible Assets, Net (Excluding Goodwill), Total	769	929
Total Assets	8,858	12,196
Current liabilities
Accounts payable	52	69
Accrued expenses	739	969
Deferred revenue	0	12
Total current liabilities	791	1,050
Warrant liability	0	2,906
Total Liabilities	791	3,956
Shareholders’ equity
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $.001 par value; 200,000 shares authorized; 11,339 and 9,564 shares issued and outstanding, respectively	11	10
Additional paid in capital	47,213	40,364
Accumulated deficit	(39,157)	(32,134)
Total shareholders’ equity	8,067	8,240
Total Liabilities & Shareholders’ Equity	$ 8,858	$ 12,196